International Conf on Alzheimer Disease and Related Disorders in the Middle East
International Conf on Alzheimer Disease and Related Disorders in the Middle East
批准号:
8528926
负责人:
CHANGIZ GEULA
金额:
$4.05万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2014-03-31
关键词:
AddressAffectAgingAlzheimer&aposs DiseaseAmericasArabsAreaAttentionAwarenessBahrainBasic ScienceBehavioralBiotechnologyBrain DiseasesCanadaCaringClinical SciencesCollaborationsCommunicationCommunitiesConsanguinityCountryDementiaDiagnosisDietDisabled PersonsDiseaseEducationEgyptElderlyEnsureEpidemicEthicsEuropeFatty acid glycerol estersFeedbackFosteringFundingFutureGenerationsGoalsGovernmentHealthHuman ResourcesIndividualInternationalInvestigationIranIsraelJordanJournalsLeadLearningLebanonLinkLogisticsMedicalMeleagris gallopavoMiddle EastMilitary PersonnelMolecular GeneticsMuseumsNeurodegenerative DisordersNeurologyNorth AmericaNursesOralPalestinianParticipantPatientsPharmacologic SubstancePoliciesPopulationPopulation SizesPostdoctoral FellowPublic PolicyPublishingQatarRecording of previous eventsResearchResearch PersonnelSaudi ArabiaScientistSmokingSocial WorkersStudentsSuggestionSyriaTimeTunisiaUnited Arab EmiratesUniversitiesWest BankWomanWorkabstractingage groupagedauthoritybaseclinical Diagnosisexperiencefollower of religion Jewishgraduate studenthandicapping conditionimprovedlecturesmedical attentionmeetingsmild cognitive impairmentpostersprofessorprogramspublic health relevancesocialsuccesssymposium
中文摘要
描述(由申请人提供):阿尔茨海默病是美洲和欧洲的主要健康问题和痴呆症的主要原因。中东地区对痴呆症的研究很少。这是一个重要的问题,因为包括中东在内的世界人口正在逐渐老龄化。例如,从2000年到2030年,埃及60岁及以上人口的规模预计将增加316%。此外,在中东,公众对痴呆症的认识很低,在许多情况下,痴呆症患者没有得到医疗照顾。本提案的目标是为第六届中东阿尔茨海默病及相关疾病国际会议获得支持。本次会议的目的是集中关注中东地区老年人的神经退行性疾病,特别是阿尔茨海默病,提高科学、医学和社会对这些疾病的认识,并加强阿拉伯和犹太医疗和科学人员之间的交流,以及中东工人与其他国家,特别是美国同行之间的交流。预计这次会议将导致增加对中东地区痴呆症的研究,该地区具有独特的研究价值,包括高血缘和吸烟率,相对同质的人口和高脂肪饮食。主要组织者来自中东,对该地区的文化传统非常熟悉,并与这些会议的前任组织者一起,与中东地区的工作人员建立了持续的合作关系。临床医生、科学家、护士、社会工作者、政府代表和其他机构、制药公司和其他生物技术公司等目标受众将出席于2013年3月23日至24日在土耳其伊斯坦布尔举行的会议。与会者将来自大多数中东国家,包括巴林、埃及、伊朗、以色列、约旦、黎巴嫩、巴勒斯坦权力机构、卡塔尔、沙特阿拉伯、叙利亚、突尼斯、土耳其、阿拉伯联合酋长国和约旦河西岸,并将包括来自欧洲、北美和世界其他地区的工人。涉及的主题包括痴呆症的临床和基础科学方面,诊断,历史,管理,治疗和伦理,并考虑到阿拉伯和犹太人口独特的文化传统。组织者过去已经成功地召开了五届会议,根据以往的经验,希望第六届会议更加成功。
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease is a major health problem and the leading cause of dementia in the Americas and Europe. There has been little work done on dementia in the Middle East. This is an important issue because of the progressive aging of the populations of the world, including the Middle East. For example, the size of the population of Egyptians 60 years and older is expected to increase by 316% from 2000 to 2030. Also, public awareness of dementia in the Middle East is low, and in many cases demented patients do not receive medical attention. The goal of this proposal is to obtain support for the Sixth International Conference on Alzheimer's Disease and Related Disorders in the Middle East. The objectives of this conference are to focus attention on neurodegenerative disorders of the aged, particularly Alzheimer's Disease, in the Middle East, to raise scientific, medical and social awareness of these disorders, and to enhance communication between Arab and Jewish medical and scientific personnel as well as communication between Middle Eastern workers and their counterparts in other countries, particularly the USA. It is anticipated that the meetin will lead to increased studies of dementia in the Middle East, a region with unique features valuable for research, including a high rate of consanguinity and smoking, relatively homogenous populations, and high fat diet. The primary organizers are from Middle Eastern background and are thoroughly familiar with the cultural traditions of the region, and along with the past organizer of these conferences, have built continuing collaborative relationships with works in the Middle East. A target audience of clinicians, scientists, nurses, social workers, government representatives and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in Istanbul, Turkey, March 23-24, 2013. Attendees will be from the majority of Middle Eastern countries including Bahrain, Egypt, Iran, Israel, Jordan, Lebanon, Palestinian Authority, Qatar, Saudi Arabia, Syria, Tunisia, Turkey, United Arab Emirates and the West Bank and will include will include workers from Europe, North America and other parts of the world. Topics to be covered include clinical and basic science aspects of dementia, diagnoses, history, management, treatment, and ethics, with consideration of the unique cultural traditions of Arab and Jewish populations. The organizers have successfully convened five editions of this conference in the past, and based on past experience expect an even more successful sixth conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10901316
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2023
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10276525
-
项目类别:
-
资助金额:$413.0万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10469453
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10276530
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10687278
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10264374
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10687271
-
项目类别:
-
资助金额:$127.95万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10662493
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10359727
-
项目类别:
-
资助金额:$75.18万
-
财政年份:2020
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10004183
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:9788539
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10248370
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
7th Intern Conf on AD and Related Disorders in the Middle East
-
批准号:9261277
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:8896086
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9918541
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9056631
-
项目类别:
-
资助金额:$46.73万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Generation of High Passage and Immortalized Human Microglia Cell Lines
-
批准号:8797358
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9923902
-
项目类别:
-
资助金额:$68.56万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:10600105
-
项目类别:
-
资助金额:$66.79万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9326361
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
海外基金